Browse By Cancer Type Result Page of OvirusTdb

The total number of records retrieved from this search are 100. Click on ID to see further detail.

ID	Virus name	Virus strain	Virus genome type	Virus family	Virus genome modification	Virus alone	Virus in combination with drug/radiation	Immune gene insertion in viral genome	Source of cell line	Origin of cell line	Cell line	Concentration of cell line	In-vitro toxicity	Assay	In-vitro virus concentration	In-vitro result	Model organism	In-vivo virus concentration	In-vivo toxicity	In-vivo result	Mode of delivery	Pathway induced	Immunogenic effect	Clinical trial	PMID
OV_606	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	Key Laboratory of Zoonosis, Jilin University	Human prostate cancer cell line	PC-3M	1.0E+5 cells per well	NA	MTT assay	0.1 MOI	70% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_609	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	Key Laboratory of Zoonosis, Jilin University	Human prostate cancer cell line	PC-3M	1.0E+5 cells per well	NA	MTT assay	1 MOI	40% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_612	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	Key Laboratory of Zoonosis, Jilin University	Human prostate cancer cell line	PC-3M	1.0E+5 cells per well	NA	MTT assay	10 MOI	18% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_615	Adenovirus	CRAd-CCL21-IL15	DNA	Adenoviridae	Insertion mutant for CCL21 and IL15 genes with TERTp to target the TERT-positive cancer cells	Yes	No	IL-15	Key Laboratory of Zoonosis, Jilin University	Human prostate cancer cell line	PC-3M	1.0E+5 cells per well	NA	MTT assay	50 MOI	10% cancer cell viability	No	No	NA	No response	NA	NA	NA	NA	27380620
OV_887	Herpes simplex virus	Mutant	DNA	Herpesviridae	Deletion mutant for Gamma 34.5	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+4 cells per well	NA	Trypan blue staining and hematocytometer	0.1 pfu/ml	85% cncer cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12788648
OV_890	Herpes simplex virus	Mutant	DNA	Herpesviridae	Deletion mutant for Gamma 34.5	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+4 cells per well	NA	Trypan blue staining and hematocytometer	0.1 pfu/ml	95% cncer cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12788648
OV_893	Herpes simplex virus	Mutant	DNA	Herpesviridae	Deletion mutant for Gamma 34.5	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+4 cells per well	NA	Trypan blue staining and hematocytometer	0.01 pfu/ml	80% cncer cell killing after 24 hours	No	No	NA	No response	NA	NA	NA	NA	12788648
OV_896	Herpes simplex virus	Mutant	DNA	Herpesviridae	Deletion mutant for Gamma 34.5	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+4 cells per well	NA	Trypan blue staining and hematocytometer	0.01 pfu/ml	80% cncer cell killing after 48 hours	No	No	NA	No response	NA	NA	NA	NA	12788648
OV_898	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	2% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_899	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	20% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_900	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	50% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_901	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	20% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_902	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	40% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_903	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	80% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_904	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	60% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_905	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	80% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_906	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.01 pfu/cell	90% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_907	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	20% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_908	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	30% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_909	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	50% cancer cell killing after 24 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_910	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	50% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_911	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	60% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_912	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	100% cancer cell killing after 48 hour	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_913	Herpes simplex virus	Baco-1	DNA	Herpesviridae	Non- fusogenic ligated with EGFP protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	60% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_914	Herpes simplex virus	Synco-2	DNA	Herpesviridae	Fusogenic membrane ligated with GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	80% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_915	Herpes simplex virus	Synco-2D	DNA	Herpesviridae	Double fusogenic expressing EGFP and GALV.fus protein	Yes	No	No	ATCC	Prostate cancer cell line	PC-3M-Pro4	5.0E+4 cells per well	NA	Trypan blue staining	0.1 pfu/cell	100% cancer cell killing after 72 hours	No	No	NA	No response	NA	NA	NA	NA	15129429
OV_1139	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	3.0E+5 cells per well	NA	MTT assay	0.01MOI	Kill cancer cell line after 3 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1140	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	3.0E+5 cells per well	NA	MTT assay	0.1MOI	Kill cancer cell line after 3 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1141	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+5 cells per well	NA	MTT assay	0.01MOI	No cell killing after 3 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1142	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+5 cells per well	NA	MTT assay	0.1MOI	No cell killing after 3 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1143	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+5 cells per well	NA	MTT assay	0.01MOI	70% cell killing after 4 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1144	Herpes simplex virus	Mutant	DNA	Herpesviridae	Mutant for gamma 34.5, lacZ and alpha 47 gene	Yes	No	No	ATCC	Human prostate cancer cell line	Du145	3.0E+5 cells per well	NA	MTT assay	0.1MOI	70% cell killing after 4 days	No	No	NA	No response	NA	NA	NA	NA	16278413
OV_1260	Adenovirus	AxdAdb-3	DNA	Adenoviridae	Double mutated for E1A and E1B gene	Yes	No	No	ATCC	Prostate cancer cell line	Du145	3.0E+3 cells per well		MTT assay	30 MOI	Surviving cell number reached to 1000	No	No	NA	No response	NA	NA	NA	NA	18063085
OV_1261	Adenovirus	AxdAdb-3	DNA	Adenoviridae	Double mutated for E1A and E1B gene	Yes	No	No	ATCC	Prostate cancer cell line	PC-3	3.0E+3 cells per well		MTT assay	30 MOI	Surviving cell number reached to 10000	No	No	NA	No response	NA	NA	NA	NA	18063085
OV_1262	Adenovirus	AxdAdb-3	DNA	Adenoviridae	Double mutated for E1A and E1B gene	Yes	No	No	ATCC	Prostate cancer cell line	LNCaP	3.0E+3 cells per well		MTT assay	30 MOI	Surviving cell number reached to 1000	No	No	NA	No response	NA	NA	NA	NA	18063085
OV_1278	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viablity after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1279	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	90% cell viablity after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1280	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	70% cell viabilty after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1281	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1282	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	100% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1283	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	70 % cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1284	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	20% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1285	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1286	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	80% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1287	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	50% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1288	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	20% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1289	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	LNCaP	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1290	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1291	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	90% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1292	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	100% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1293	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	98% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1294	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	98% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1295	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	80% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1296	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	70% cell viability after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1297	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	60% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1298	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	60% cell viability after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1299	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	40% cell viability after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1300	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	30% cell viability afterd ay 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1301	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PC-3	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	20% cell viability after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1302	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	No significant effect on cell death after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1303	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	No significant effect on cell death after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1304	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	No significant effect on cell death after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1305	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	0.1 MOI	No significant effect on cell death after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1306	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	No significant effect on cell death after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1307	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	No significant effect on cell death after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1308	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	No significant effect on cell death after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1309	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	1 MOI	No significant effect on cell death after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1310	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	No significant effect on cell death after day 1	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1311	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	No significant effect on cell death after day 2	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1312	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	No significant effect on cell death after day 3	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1313	Adenovirus	OBP-301	DNA	Adenoviridae	None	Yes	No	No	ATCC	Human prostate cancer cell line	PrEC	1000 cells per well	NA	Cell proliferation kit by Roche Diagnostics	10 MOI	No significant effect on cell death after day 4	No	No	NA	No response	NA	NA	NA	NA	18274558
OV_1800	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	100% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1801	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	100% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1802	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	90% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1803	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	80% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1804	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	90% cell survival after 120 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1805	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	98% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1806	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	80% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1807	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	70% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1808	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	60% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1809	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	90% cell survival after 120 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1810	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	10 MOI	90% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1811	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	10 MOI	60% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1812	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	10 MOI	60% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1813	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	10 MOI	40% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1814	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	10 MOI	50% cell survival after 120 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1815	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	50 MOI	80% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1816	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	50 MOI	30% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1817	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	50 MOI	10% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1818	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	50 MOI	10% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1819	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	Virus expressing GFP protein	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	50 MOI	100% cell killing	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1820	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	100% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1821	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	90% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1822	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	80% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1823	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	80% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1824	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	1MOI	90% cell survival after 120 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1825	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	90% cell survival after 24 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1826	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	70% cell survival after 48 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1827	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	60% cell survival after 72 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545
OV_1828	Vesicular stomatitis virus	Mutant	RNA	Rhabdoviridae	virus expressing SV5-F gene	Yes	No	No	ATCC	Prostate cancer cell line	TRAMP-C2	2.0E+3 cells per well	NA	MTT assay	5 MOI	50% cell survival after 96 hours	No	No	NA	No response	NA	Virus induce apoptosis in cancer cells	NA	NA	20172545

previous12 3 next